COVID-19–RELATED LUNG INJURY: A HISTOPATHOLOGICAL OVERVIEW
Downloads
Objective: To provide a comprehensive review of the key histopathological features associated with COVID-19–related lung injury and to clarify the extent of vascular and inflammatory involvement in the disease. Method: A literature review analyzing reported histopathological findings in COVID-19 lung specimens, comparing them with other viral infections such as H1N1 influenza, and correlating them with clinical and radiological data. Results: Findings consistently highlight diffuse alveolar damage (exudative and proliferative phases), type II pneumocyte hyperplasia, squamous metaplasia, intra-alveolar hemorrhage, microthrombosis, and occasional osseous metaplasia. Additional observations include inflammatory infiltrates, endothelial injury, and cytokine-related damage (e.g., IL-6 upregulation). COVID-19 shows more extensive alveolar and vascular involvement than many other viral infections, though findings vary across patients and comorbidities. Novelty: The review underscores that although several histopathological features overlap with other viral pneumonias, the severity of vascular injury and the complexity of the inflammatory response in COVID-19 distinguish it. It also stresses the diagnostic value of integrating histopathological, clinical, and radiological evidence to better understand disease pathogenesis.
N. Zhu et al., “A novel coronavirus from patients with pneumonia in China, 2019,” N. Engl. J. Med., vol. 382, pp. 727–733, 2020.
A. J. Rodriguez-Morales et al., “Preparación y control de la enfermedad por coronavirus 2019 (COVID-19) en América Latina,” Acta Méd. Peru., vol. 37, pp. 3–7, 2020.
J. A. Sánchez-Duque, L. R. Arce-Villalobos, and A. J. Rodríguez-Morales, “Enfermedad por coronavirus 2019 (COVID-19) en América Latina: papel de la atención primaria en la preparación y respuesta,” Atención Primaria, vol. 52, pp. 369–372, 2020.
Pan American Health Organization/World Health Organization, “Epidemiological update: coronavirus disease (COVID-19),” Washington, D.C., May 22, 2020.
C. Basso et al., “Feasibility of postmortem examination in the era of COVID-19 pandemic: The experience of a Northeast Italy University Hospital,” Virchows Arch., vol. 477, pp. 341–347, 2020.
M. Tabary et al., “Pathologic features of COVID-19: A concise review,” Pathol. Res. Pract., vol. 216, p. 153097, 2020.
L. Falasca et al., “Postmortem findings in Italian patients with COVID-19,” J. Infect. Dis., vol. 222, pp. 1807–1815, 2020.
A. Maiese, G. Piscopo, A. Barone, and C. Turillazzi, “Autopsy findings in COVID-19-related deaths: a literature review,” Forensic Science, Medicine and Pathology, vol. 17, no. 2, pp. 279–285, 2021
R. F. Barth, X. Xu, and L. M. Buja, “A call to action: the need for autopsies to determine the full extent of organ involvement associated with COVID-19,” Chest, vol. 158, pp. 43–44, 2020.
A. C. Borczuk et al., “COVID-19 pulmonary pathology: A multi-institutional autopsy cohort from Italy and New York City,” Mod. Pathol., vol. 33, pp. 2156–2168, 2020.
S. K. Mohanty et al., “SARS-CoV-2 and COVID-19—anatomic pathology perspective on current knowledge,” Diagn. Pathol., vol. 15, p. 103, 2020.
D. Wichmann et al., “Autopsy findings and venous thromboembolism in patients with COVID-19,” Ann. Intern. Med., vol. 173, pp. 268–277, 2020.
B. Zhou et al., “The pathological autopsy of COVID-19 in China: A review,” Pathog. Dis., vol. 78, 2020.
M. Ackermann et al., “Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19,” N. Engl. J. Med., vol. 383, pp. 120–128, 2020.
F. Calabrese et al., “Pulmonary pathology and COVID-19: Lessons from autopsy,” Virchows Arch., vol. 477, pp. 359–372, 2020.
T. Adachi et al., “Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19, Japan,” Emerg. Infect. Dis., vol. 26, pp. 2157–2161, 2020.
S. E. Fox et al., “Pulmonary and cardiac pathology in African American patients with COVID-19,” Lancet Respir. Med., vol. 8, pp. 681–686, 2020.
L. M. Buja et al., “The emerging spectrum of cardiopulmonary pathology of COVID-19,” Cardiovasc. Pathol., vol. 48, p. 107233, 2020.
T. Menter et al., “Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion,” Histopathology, vol. 77, pp. 198–209, 2020.
C. Edler et al., “Dying with SARS-CoV-2 infection—an autopsy study,” Int. J. Legal Med., vol. 134, pp. 1275–1284, 2020.
B. T. Bradley et al., “Histopathology and ultrastructural findings of fatal COVID-19 infections,” Lancet, vol. 396, pp. 320–332, 2020.
V. Deshmukh et al., “Histopathological observations in COVID-19: A systematic review,” J. Clin. Pathol., 2020.
S. Tian et al., “Pathological study of COVID-19 through postmortem core biopsies,” Mod. Pathol., vol. 33, pp. 1007–1014, 2020.
T. Schaller et al., “Postmortem examination of patients with COVID-19,” JAMA, vol. 323, pp. 2518–2520, 2020.
S. De Michele et al., “Forty postmortem examinations in COVID-19 patients,” Am. J. Clin. Pathol., vol. 154, pp. 748–760, 2020.
C. Shanmugam et al., “COVID-2019—A comprehensive pathology insight,” Pathol. Res. Pract., vol. 216, p. 153222, 2020.
M. C. Copin et al., “Time to consider histologic pattern of lung injury to treat critically ill COVID-19 patients,” Intensive Care Med., vol. 46, pp. 1124–1126, 2020.
G. Zubieta-Calleja and N. Zubieta-DeUrioste, “Pneumolysis and silent hypoxemia in COVID-19,” Indian J. Clin. Biochem., vol. 9, pp. 1–5, 2020.
M. Yang et al., “Pathological findings in testes of COVID-19 patients,” Eur. Urol. Focus, vol. 6, pp. 1124–1129, 2020.
T. Menter et al., “Post-mortem examination of COVID-19 patients reveals diffuse alveolar damage…,” Histopathology, 2020, doi: 10.1111/his.14134.
S. E. Fox et al., “Pulmonary and cardiac pathology in COVID-19: The first autopsy series from New Orleans,” Lancet Respir. Med., 2020.
G. M. Kuster et al., “SARS-CoV-2: should inhibitors of the renin–angiotensin system be withdrawn?” Eur. Heart J., vol. 41, pp. 1801–1803, 2020.
S. Tang et al., “Pathological study of COVID-19 through post-mortem core biopsies,” Mod. Pathol., 2020.
A. Kimball et al., “Asymptomatic and presymptomatic SARS-CoV-2 infections in a nursing facility,” MMWR, vol. 69, pp. 377–381, 2020.
M. M. Arons et al., “Presymptomatic SARS-CoV-2 infections and transmission,” N. Engl. J. Med., 2020.
Y. Luo et al., “Asymptomatic SARS-CoV-2 infection in household contacts,” Emerg. Infect. Dis., vol. 26, 2020.
C. Zhang, L. Shi, and F. S. Wang, “Liver injury in COVID-19,” Lancet Gastroenterol. Hepatol., vol. 5, pp. 428–430, 2020.
J. Zhou et al., “Active replication of MERS-CoV…,” J. Infect. Dis., vol. 209, pp. 1331–1342, 2014.
W. J. Guan et al., “Clinical characteristics of COVID-19 in China,” N. Engl. J. Med., vol. 382, pp. 1708–1720, 2020.
Z. Huilan et al., “Histopathologic changes and SARS-CoV-2 immunostaining,” Ann. Intern. Med., vol. 172, 2020.
F. K. Kommoss et al., “The pathology of severe COVID-19-related lung damage,” Dtsch. Ärztebl. Int., vol. 117, pp. 500–510, 2020.
C. Suess and R. Hausmann, “Pulmonary findings in COVID-19 associated death during self-isolation,” Int. J. Legal Med., vol. 134, pp. 1285–1290, 2020.
C. Doglioni et al., “COVID-19 interstitial pneumonia: histological and immunohistochemical features,” Respiration, vol. 100, pp. 488–498, 2021.
M. A. Montero-Fernandez and R. Pardo-Garcia, “Histopathology features of the lung in COVID-19 patients,” Diagn. Histopathol., vol. 27, pp. 123–127, 2021.
World Health Organization, Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, 2020.
Centers for Disease Control and Prevention, Interim guidance for healthcare facilities: preparing for community transmission of COVID-19, 2020.
S. S. Tan et al., “Practical laboratory considerations amidst the COVID-19 outbreak,” J. Clin. Pathol., 2020.
P. C. Iwen, K. L. Stiles, and M. A. Pentella, “Safety considerations in laboratory testing of specimens containing SARS-CoV-2,” Am. J. Clin. Pathol., 2020.
U. Malapelle et al., “Predictive molecular pathology in the time of COVID-19 in Europe,” J. Clin. Pathol., 2020.
S. T. J. Balaky et al., “A comprehensive review of histopathological findings…” Cell Mol. Biol., vol. 66, no. 7, pp. 143–151, 2020.
G. Zarrilli et al., “The immunopathological and histological landscape of COVID-19-mediated lung injury,” Int. J. Mol. Sci., vol. 22, p. 974, 2021.
Copyright (c) 2025 Zainab M Jawad Alkhirsan, Esraa A. Alyasiry, Ali M Hussein Abdulhadi
This work is licensed under a Creative Commons Attribution 4.0 International License.
